Stocks · Health care · Surgical & Medical Instruments & Apparatus

Becton Dickinson

BDX Clue Score44
United States Fiscal year ends September CIK 0000010795 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Roland Goette
11 Aug 2026
EVP and President, EMEA
Sell
2,438
$180.84
$440.89K
Bertram L Scott
18 Feb 2026
Director
Sell
953
$182.61
$174.03K
Bertram L Scott
7 Nov 2025
Director
Sell
217
$176.58
$38.32K
Claire Fraser
10 Sep 2025
Director
Sell
917
$187.50
$171.94K
Claire Fraser
8 Aug 2025
Director
Sell
863
$192.30
$165.95K
Bertram L Scott
12 Feb 2025
Director
Sell
700
$227.99
$159.59K
Claire Fraser
28 Aug 2023
Director
Sell
848
$281.66
$238.85K
Richard Byrd
3 Feb 2023
EVP & President Interventional
Sell
1,421
$248.60
$353.26K
David Hickey
15 Aug 2022
EVP & President, Life Sciences
Sell
475
$265.00
$125.88K
Samrat S. Khichi
8 Aug 2022
EVP and General Counsel
Sell
7,295
$260.44
$1.90M
David Hickey
6 May 2022
EVP & President, Life Sciences
Sell
475
$256.00
$121.60K
Claire Fraser
8 Feb 2022
Director
Sell
841
$271.70
$228.50K
Thomas J Spoerel
7 Dec 2021
VP Controller & Chief Acct Off
Sell
233
$250.00
$58.25K
Rebecca W Rimel
8 Sep 2021
Director
Sell
500
$260.00
$130.00K
David Hickey
8 Sep 2021
EVP & President, Life Sciences
Sell
500
$260.00
$130.00K
Thomas J Spoerel
8 Sep 2021
VP Controller & Chief Acct Off
Sell
267
$260.00
$69.42K
Rebecca W Rimel
3 Sep 2021
Director
Sell
500
$257.10
$128.55K
Rebecca W Rimel
2 Sep 2021
Director
Sell
244
$254.00
$61.98K
Rebecca W Rimel
30 Aug 2021
Director
Sell
207
$252.00
$52.16K
Claire Fraser
18 Aug 2021
Director
Sell
387
$251.58
$97.36K
Rebecca W Rimel
17 Aug 2021
Director
Sell
207
$252.00
$52.16K
Thomas J Spoerel
6 Aug 2021
VP Controller & Chief Acct Off
Sell
266
$242.30
$64.45K
James C Lim
28 May 2021
Executive Vice President
Sell indirect
3,429
$241.68
$828.72K
Claire Fraser
27 May 2021
Director
Sell
390
$241.36
$94.13K
Patrick Kaltenbach
9 Jul 2020
EVP & Pres Life Sciences
Sell
1,272
$260.00
$330.72K
Patrick Kaltenbach
5 Jun 2020
EVP & Pres Life Sciences
Sell
1,049
$243.20
$255.12K
Patrick Kaltenbach
2 Jun 2020
EVP & Pres Life Sciences
Sell
222
$244.83
$54.35K
Claire Fraser
8 May 2020
Director
Sell
771
$256.56
$197.81K
Samrat S. Khichi
16 Mar 2020
EVP and General Counsel
Sell
4,349
$224.53
$976.48K
Claire Fraser
11 Feb 2020
Director
Sell
700
$258.70
$181.09K
Claire Fraser
11 Feb 2020
Director
Sell
800
$258.73
$206.98K
Ribo Alberto Mas
4 Feb 2020
EVP and Pres, Life Sciences
Sell
1,430
$285.00
$407.55K
Thomas J Spoerel
13 Dec 2019
VP Controller & Chief Acct Off
Sell
506
$267.95
$135.58K
Patrick Kaltenbach
6 Dec 2019
EVP & Pres Life Sciences
Sell
312
$261.51
$81.59K
Alexandre Conroy
30 Aug 2019
EVP of Integrated Supply Chain
Sell
46
$256.72
$11.81K
Alexandre Conroy
29 Aug 2019
EVP of Integrated Supply Chain
Sell
9,829
$255.06
$2.51M
Patrick Kaltenbach
9 Aug 2019
EVP & Pres Life Sciences
Sell
127
$253.78
$32.23K
Claire Fraser
7 Aug 2019
Director
Sell
1,429
$243.26
$347.62K
Simon D Campion
12 Jun 2019
EVP and Segment President
Sell
2,903
$236.94
$687.84K
Patrick Kaltenbach
4 Jun 2019
EVP & Pres Life Sciences
Sell
275
$235.00
$64.63K
Samrat S. Khichi
21 May 2019
EVP and General Counsel
Sell
16,085
$234.68
$3.77M
Catherine M Burzik
17 Apr 2019
Director
Sell
45
$223.04
$10.04K
Ribo Alberto Mas
14 Nov 2018
EVP and Pres, Life Sciences
Sell
4,530
$237.01
$1.07M
James C Lim
8 Nov 2018
Executive Vice President
Sell
5,189
$242.36
$1.26M
Timothy M Ring
7 Nov 2018
Director
Sell
42,000
$237.07
$9.96M
John E Gallagher
28 Feb 2018
VP, Corp Finance and Treasurer
Sell
9
$226.30
$2.04K
Timothy M Ring
23 Feb 2018
Director
Sell indirect
176
$218.27
$38.42K
James C Lim
8 Sep 2017
Executive Vice President
Sell
3,500
$204.06
$714.21K
Nabil Shabshab
15 Aug 2017
Executive Vice President
Sell
2,865
$202.37
$579.79K
Alexandre Conroy
14 Feb 2017
Executive Vice President
Sell
8,500
$177.86
$1.51M
John E Gallagher
15 Dec 2016
VP, Corp Finance and Treasurer
Sell
1,793
$168.82
$302.69K
Stephen Sichak
5 Dec 2016
Executive Vice President
Sell
2,632
$164.44
$432.81K

What was left out

Form 4 filings counted 590
Amendments (4/A) skipped 10
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 43
Sales straight out of an exercise 106
Sales at will 52
Transactions with no price 0
Shares from compensation/vesting 3,555,897
Sales filed before the plan box existed 45
History held since 2 Nov 2006